These emerging therapies , Retatrutide, represent a remarkable advancement in addressing metabolic dysfunction and potentially related ailments . They are categorized as GLP-1 hormone agonists , https://harmonyjotf605049.onzeblog.com/41580592/tirzepatide-a-deep-examination-into-glp-1-compounds